Skip to main content
. 2023 Feb 27;17(7):1055–1065. doi: 10.1093/ecco-jcc/jjad022

Figure 4.

Figure 4.

Prevalence of adverse events in the mercaptopurine and placebo group per month. The number on the x-axis corresponds to the number of the month in which adverse events occurred.